The burden of inflammatory bowel disease in Europe in 2020

M Zhao, L Gönczi, PL Lakatos… - Journal of Crohn's and …, 2021 - academic.oup.com
New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

J Burisch, M Zhao, S Odes, P De Cruz… - The Lancet …, 2023 - thelancet.com
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

T Raine, S Bonovas, J Burisch… - Journal of Crohn's …, 2022 - academic.oup.com
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

J Burisch, H Vardi, D Schwartz, M Friger… - The lancet …, 2020 - thelancet.com
Background Inflammatory bowel disease (IBD) places a significant burden on health-care
systems because of its chronicity and need for expensive therapies and surgery. With …

Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents

RCA van Linschoten, E Visser… - Alimentary …, 2021 - Wiley Online Library
Background Knowledge of the cost of illness of inflammatory bowel disease (IBD) is
essential for health policy makers worldwide. Aim To assess the cost of illness of IBD from …

The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies

B Lo, M Zhao, I Vind, J Burisch - Clinical Gastroenterology and Hepatology, 2021 - Elsevier
Background & Aims Patients with Crohn's disease (CD) and ulcerative colitis (UC) are at
increased risk of developing intestinal cancer. However, less is known about the risk of …

Accuracy of ultrasound for evaluation of colorectal segments in patients with inflammatory bowel diseases: a systematic review and meta-analysis

S Sagami, T Kobayashi, Y Miyatani… - Clinical …, 2021 - Elsevier
Background & Aims The accuracy of ultrasound for evaluation of individual colorectal
segments in patients with inflammatory bowel diseases (IBD) has not been evaluated in a …

Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases–a Danish nationwide cohort study

M Zhao, M Sall Jensen, T Knudsen… - Alimentary …, 2022 - Wiley Online Library
Background Therapeutic management of inflammatory bowel diseases (IBD) is rapidly
evolving, with an expanding armoury of biological drugs at our disposal. However, real …

Crohn's disease

M Dolinger, J Torres, S Vermeire - The Lancet, 2024 - thelancet.com
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract that might lead
to progressive bowel damage and disability. The exact cause of Crohn's disease is …

The incidence and prevalence of paediatric-and adult-onset inflammatory bowel disease in Denmark during a 37-year period: a nationwide cohort study (1980–2017)

M Dorn-Rasmussen, B Lo, M Zhao… - Journal of Crohn's …, 2023 - academic.oup.com
Background Incidence rates of inflammatory bowel disease [IBD] reported from developed
countries are rising, with some levelling out. The aim of this study was to assess the disease …